The recent universal definition of heart failure specifies an ambulatory NT-proBNP above 125 pg/mL as a corroborating factor when considering a diagnosis of heart failure when accompanied by symptoms or signs of the disease.1 Even outside of a diagnosis of heart failure or obvious structural heart disease, this threshold has also been linked to future cardiovascular events. This evidence concerns the gene NPPB and heart failure.